All entries for: Corvus Pharmaceuticals, Inc.

May 7, 2026

Corvus Pharmaceuticals, Inc.

Neutral Outlook

Burlingame, CA
51-200 employees

While the impact of the IRA on the pharmaceutical industry cannot yet be fully determined, it is likely to be significant.

Disease Area: Dermatology, Hematology, Immune Diseases, Oncology
Drug Type: Biologic, Small Molecule
March 12, 2026

Corvus Pharmaceuticals, Inc.

Neutral Outlook

Burlingame, CA
51-200 employees

For that and other reasons, it is currently unclear how the IRA will be effectuated.

Disease Area: Dermatology, Hematology, Immune Diseases, Oncology
Drug Type: Biologic, Small Molecule
Scroll to Top